As some companies struggle with flu plans, others profit from pandemic

Published on November 4, 2009; Published on June 30, 2010
The Canadian Press ~ The News

Topics :: TSX , Bank of Montreal , BMO , Quebec City

Many Canadian companies expect the H1N1 flu to hand them staff shortages and dropping revenue, but others are looking to turn a healthy profit.
The Bank of Montreal (TSX:BMO) has calculated that a mild pandemic would cut annual economic growth by two percentage points, while a severe outbreak would cut growth by six percentage points.
But not all businesses will suffer from the pandemic.
Medical equipment maker Noveko International Inc. (TSX:EKO) says it's received so many orders for its face masks that it's had to turn some down, while demand for its hand sanitizer has gone through the roof.
And Montreal-based AXA Assistance has launched a pandemic assistance hotline to help companies reduce the disruption in their day-to-day activities due to the flu.
Meanwhile, Glaxo Smith Kline's (NYSE:GSK) facility in Quebec City has already produced seven million doses of H1N1 vaccine and expects to produce millions more in the weeks ahead.

Rate
Top of the page

Submit a comment

Submit a comment Your name* Email* (we keep all emails private) Write your comment here*

Agreement

We ask that users remain courteous. You may not post insulting, discriminatory or inappropriate content, which may be removed at our discretion. We are not responsible for user content and opinions. Use of this site as well as content submission & ownership are governed by our Conditions of Use and Privacy Policy.

Member organizations should be non-profit in nature, and promote legal activities. Any organization found promoting illegal activities or commercial products or services will be deleted from the site.

I agree with these conditions.